Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial
Authors:
- The Bemiparin DVT Study GroupTGThe Bemiparin DVT Study Group
- Igor A. SuchkovISIgor A. Suchkov
- Javier Martinez-GonzalezJMJavier Martinez-Gonzalez
- 6 December 2017
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 38 (2) , 181-189
Abstract
Individuals with deep vein thrombosis (DVT) have an increased risk of pulmonary embolism (PE), death, and long-term thrombotic complications.Keywords
Funding Information
- This study was funded by Berlin-Chemie AG. Medical writing assistance was funded by Berlin-Chemie AG and Laboratorios Farmaceuticos Rovi S.A.
This publication has 27 references indexed in Scilit:
- Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosisThrombosis and Haemostasis, 2014
- Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic reviewBritish Journal of Haematology, 2011
- Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939)Circulation, 2007
- Fixed‐dose low‐molecular‐weight heparin, bemiparin, in the long‐term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS studyJournal of Thrombosis and Haemostasis, 2006
- Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA StudyInternational Journal Of Clinical Practice, 2006
- The management of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 2006
- Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: A systematic reviewThe American Journal of Medicine, 2005
- Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low‐molecular‐weight heparins: a meta‐analysisJournal of Thrombosis and Haemostasis, 2004
- Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein ThrombosisNew England Journal of Medicine, 2001
- A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous ThromboembolismArchives of internal medicine (1960), 2000